Comments
Loading...
Edgewise Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:EWTX | Benzinga
Edgewise Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.370
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Edgewise Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Edgewise Therapeutics (EWTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $-0.42 | $-0.40 | -5.00 % |
| Q3 | 2024-11-07 | $-0.36 | $-0.37 | 2.70 % |
| Q2 | 2024-08-08 | $-0.34 | $-0.36 | 5.56 % |
| Q1 | 2024-05-09 | $-0.33 | $-0.39 | 15.4 % |
Edgewise Therapeutics (EWTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Edgewise Therapeutics (NASDAQ:EWTX) reporting earnings?
Edgewise Therapeutics (EWTX) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 3, 2025 for Q4.
What were the latest earnings per share (EPS) for Edgewise Therapeutics (NASDAQ:EWTX)?
The Actual EPS was $-0.42, which missed the estimate of $-0.40.
What were Edgewise Therapeutics’s (NASDAQ:EWTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.